Literature DB >> 18650647

Lateral pelvic lymph node dissection or chemoradiotherapy: which is the procedure of choice to reduce local recurrence rate in lower rectal cancer?

Toshiaki Watanabe, Keiji Matsuda, Keijiro Nozawa, Takashi Kobunai.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18650647     DOI: 10.1097/SLA.0b013e3181820d0d

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  5 in total

Review 1.  Chemoradiotherapy and adjuvant chemotherapy for rectal cancer.

Authors:  Toshiaki Watanabe
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

Review 2.  Is There Any Reason to Still Consider Lateral Lymph Node Dissection in Rectal Cancer? Rationale and Technique.

Authors:  Miranda Kusters; Keisuke Uehara; Cornelis J H van de Velde; Yoshihiro Moriya
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

3.  Preoperative chemoradiation and extended pelvic lymphadenectomy for rectal cancer: Two distinct principles.

Authors:  Tsuyoshi Konishi; Toshiaki Watanabe; Hirokazu Nagawa; Masatoshi Oya; Masashi Ueno; Hiroya Kuroyanagi; Yoshiya Fujimoto; Takashi Akiyoshi; Toshiharu Yamaguchi; Tetsuichiro Muto
Journal:  World J Gastrointest Surg       Date:  2010-04-27

Review 4.  Diagnostic and management strategies for lateral pelvic lymph nodes in low rectal cancer-a review of the evidence.

Authors:  Dedrick Kok Hong Chan; Ker-Kan Tan; Takashi Akiyoshi
Journal:  J Gastrointest Oncol       Date:  2019-12

Review 5.  Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: Mutually exclusive or mutually beneficial?

Authors:  Tarik Sammour; George J Chang
Journal:  Ann Gastroenterol Surg       Date:  2018-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.